Australian Clinical Labs Ltd (ACL) — Long-term Investment Intensity
Australian Clinical Labs Ltd (ACL) has a Long-term Investment Intensity of 0.2% as of December 2020. Long-term investments of AU$1.00 Million represent 0.2% of total assets of AU$474.70 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check ACL cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Australian Clinical Labs Ltd Long-term Investment Intensity (2020–2020)
This chart shows how Australian Clinical Labs Ltd's Long-term Investment Intensity has evolved across 1 annual periods from 2020 to 2020. As of December 2020, the intensity stands at 0.2%, reflecting long-term investments of AU$1.00 Million against total assets of AU$474.70 Million AUD. Explore Australian Clinical Labs Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Australian Clinical Labs Ltd (2020–2020)
The table below presents the year-by-year Long-term Investment Intensity for Australian Clinical Labs Ltd from 2020 to 2020, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Australian Clinical Labs Ltd market capitalisation.
| Year | LT Investment Intensity | LT Investments (AUD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2020 | 0.2% | AU$1.00 Million | AU$474.70 Million | — |